therapeut
applic
recent
discov
small
interf
rna
sirna
gene
silenc
phenomenon
depend
improv
molecul
biostabl
specif
deliveri
address
issu
systemat
modifi
sirna
synthet
rnalik
high
affin
nucleotid
analogu
lock
nucleic
acid
lna
show
incorpor
lna
substanti
enhanc
serum
halflif
sirna
key
requir
therapeut
use
moreov
provid
evid
lna
compat
intracellular
sirna
machineri
use
reduc
undesir
sequencerel
offtarget
effect
lnamodifi
sirna
target
emerg
diseas
sar
show
improv
effici
unmodifi
sirna
certain
rna
motif
result
studi
emphas
lna
promis
convert
sirna
function
genom
technolog
therapeut
platform
author
doublestrand
small
interf
rna
sirna
molecul
drawn
much
attent
sinc
unambigu
shown
mediat
potent
gene
knockdown
varieti
mammalian
cell
work
follow
discoveri
phenomenon
rna
interfer
rnai
caenorhabd
elegan
demonstr
sirna
possibl
mediat
gene
regul
eukaryot
sirna
work
watsoncrick
basepair
rna
guid
sequenc
target
rna
follow
specif
degrad
translat
block
target
review
sirna
technolog
offer
mean
ration
design
genespecif
inhibitor
recent
year
molecul
found
widespread
use
tool
function
genom
studi
mammalian
cell
vitro
howev
applic
sirna
vivo
possibl
use
therapeut
still
face
sever
critic
hurdl
yet
comprehens
address
instanc
sirna
deliveri
biostabl
pharmacokinet
specif
includ
offtarget
effect
major
topic
investig
mani
issu
new
oligonucleotidebas
technolog
develop
drug
platform
antisens
aptam
ribozym
critic
advanc
come
develop
nucleotid
analogu
improv
properti
natur
nucleotid
recent
sever
phosphorothio
ome
oallyl
deoxyfluorouridin
examin
mean
improv
prospect
sirna
therapi
briefli
studi
demonstr
sirna
accommod
quit
number
modif
basepair
nonbasepair
posit
without
signific
loss
activ
moreov
modifi
sirna
found
exhibit
enhanc
serum
stabil
longer
durat
action
modif
end
antisens
strand
oallyl
chemic
block
hydroxyl
group
result
dramat
loss
activ
consist
propos
vivo
requir
end
phosphoryl
also
substanti
modif
total
modif
ome
ps
modif
everi
second
internucleosid
linkag
increas
cytotox
effect
result
signific
decreas
complet
loss
activ
lock
nucleic
acid
lna
famili
conform
lock
nucleotid
analogu
amongst
benefit
impos
truli
unpreced
affin
high
nucleas
resist
dna
rna
oligonucleotid
correspond
address
tel
fax
email
joacimelmen
cgbkise
onlin
version
articl
publish
open
access
model
user
entitl
use
reproduc
dissemin
display
open
access
version
articl
noncommerci
purpos
provid
origin
authorship
properli
fulli
attribut
journal
oxford
univers
press
attribut
origin
place
public
correct
citat
detail
given
articl
subsequ
reproduc
dissemin
entireti
part
deriv
work
must
clearli
indic
commerci
reus
permiss
pleas
contact
journalspermiss
oupjournalsorg
use
antisens
construct
lna
report
combin
substanti
increas
potenc
vitro
vivo
minim
toxic
also
commonli
use
lna
contain
methylen
bridg
connect
oxygen
carbon
ribos
ring
bridg
lock
ribos
ring
endo
conform
characterist
rna
lna
prime
candid
introduc
critic
new
featur
sirna
without
perturb
overal
aform
helic
structur
requir
activ
recent
braasch
et
al
provid
first
evid
lna
use
increas
thermal
stabil
sirna
molecul
without
affect
function
report
expand
earli
find
systemat
pursu
construct
biolog
test
lnamodifi
sirna
molecul
hereaft
term
silna
aim
vivo
applic
show
lna
substanti
compat
sirna
machineri
silna
exhibit
greatli
improv
biostabl
show
enhanc
inhibit
certain
rna
target
show
lna
use
reduc
sequencerel
offtarget
effect
either
lower
incorpor
sirna
sensestrand
andor
reduc
abil
inappropri
load
sensestrand
cleav
target
rna
sirna
silna
oligonucleotid
use
studi
list
tabl
lna
contain
oligonucleotid
synthes
santari
denmark
sirna
order
medprob
lund
sweden
dna
oligonucleotid
invitrogen
pais
uk
target
sequenc
describ
elsewher
firefli
luciferas
renilla
npi
sar
differ
sirna
sequenc
use
unrel
control
nonoverlap
system
plasmid
use
code
firefli
luciferas
prltk
code
renilla
luciferas
promega
madison
wi
usa
sar
target
sens
antisens
direct
respect
construct
ligat
doublestrand
dna
oligonucleotid
correspond
sar
target
site
xba
overhang
xba
site
utr
firefli
luciferas
sens
antisens
direct
insert
confirm
ligat
pcr
sequenc
melt
curv
record
perkin
elmer
uvvi
spectrophotomet
lambda
attach
peltier
system
sirnasilna
dissolv
rnasefre
buffer
mm
phosphat
buffer
mm
nacl
mm
edta
ph
final
concentr
mm
measur
cm
pathlength
cell
sampl
denatur
c
min
slowli
cool
c
prior
measur
melt
curv
record
nm
use
heat
rate
c
min
slit
nm
respons
valu
obtain
maxima
first
deriv
melt
curv
cell
line
use
human
hek
rat
monkey
vero
hek
cell
maintain
dmem
supplement
foetal
bovin
serum
penicillin
streptomycin
glutamin
maintain
dmem
supplement
hors
serum
foetal
bovin
serum
penicillin
streptomycin
glutamin
vero
cell
maintain
eagl
mem
supplement
foetal
bovin
serum
penicillin
streptomycin
glutamin
invitrogen
sarscov
frankfurt
isol
genbank
amplifi
previous
describ
inhibit
firefli
luciferas
perform
cell
cotransfect
target
plasmid
hek
cell
seed
ml
antibioticfre
medium
plate
day
transfect
allow
adher
reach
confluenc
time
transfect
standard
cotransfect
mix
prepar
triplic
sampl
ad
ng
ng
prltk
ng
sirna
ml
optimem
invitrogen
ml
lipofectamin
invitrogen
anoth
ml
optimem
two
solut
mix
incub
room
temperatur
min
ml
mix
ad
three
well
final
volum
medium
plu
transfect
mix
ml
final
sirna
concentr
nm
cell
incub
transfect
mix
h
medium
replac
new
fulli
supplement
cultur
medium
cell
harvest
h
later
luciferas
activ
measur
opposit
amount
plasmid
use
renilla
luciferas
assay
doserespons
studi
perform
analog
use
final
sirna
concentr
nm
effect
firefli
luciferas
sirna
serial
dilut
unrel
sirna
target
neuropeptid
npi
reduc
effect
amount
sirna
keep
total
sirna
concentr
constant
plasmid
use
instead
assay
effect
sens
antisens
strand
sar
sirna
silna
sirna
silna
inhibit
experi
endogen
target
npi
perform
cell
describ
without
ad
target
plasmid
final
sirna
concentr
nm
mrna
extract
h
posttransfect
inhibit
sarscovinduc
cytotox
follow
similar
procedur
sarscov
infect
sirna
transfect
vero
cell
perform
describ
previous
vero
cell
seed
plate
transfect
nm
sirna
use
lipofectamin
thereaft
infect
sarscov
cytotox
quantifi
ldh
cytotox
detect
kit
roch
penzberg
germani
h
later
luciferas
activ
assess
accord
dualluciferas
report
assay
protocol
promega
use
novostar
format
luminomet
substrat
dispens
bmg
labtechnolog
offenburg
germani
ml
sampl
place
well
plate
subsequ
ml
luciferac
assay
reagent
ii
substrat
firefli
luciferas
ad
well
luminomet
firefli
activ
measur
ml
stop
glow
stop
solut
firefli
luciferas
substrat
renilla
luciferas
ad
renilla
luciferas
activ
measur
mean
luciferas
activ
measur
read
use
calcul
ratio
firefli
renilla
luciferas
total
rna
isol
rneasi
mini
treat
rnasefre
dnase
accord
manufactur
protocol
qiagen
hilden
germani
amount
ng
dnasetr
total
rna
use
templat
first
strand
dna
synthesi
accord
manufactur
protocol
appli
biosystem
stockholm
sweden
aliquot
onetwentieth
cdna
reaction
analyz
quantit
realtim
pcr
abi
prism
appli
biosystem
genespecif
primer
probe
target
gene
npi
cyclophilin
mix
separ
taqman
univers
mastermix
appli
biosystem
ad
cdna
analyz
sampl
run
triplic
data
obtain
analyz
abi
prism
sd
softwar
appli
biosystem
duplex
sirna
silna
mm
incub
c
fetal
bovin
serum
invitrogen
dilut
phosphatebuff
salin
human
mous
serum
aliquot
ml
withdrawn
differ
time
point
immedi
frozen
ml
tbeload
buffer
sampl
tabl
sequenc
sirna
silna
use
studi
top
strand
depict
sens
strand
direct
target
sequenc
bottom
strand
depict
antisens
strand
direct
complementari
target
lna
uppercas
rna
lower
case
dna
ital
lowercas
lnac
monom
methyl
cytosin
subject
electrophoresi
polyacrylamidetb
nondenatur
condit
visual
stain
sybr
gold
quantifi
typhoon
hardwar
imagequ
softwar
amersham
bioscienc
uppsala
sweden
lna
confer
unpreced
affin
well
high
nucleas
resist
oligonucleotid
priori
suggest
lna
may
use
increas
function
halflif
sirna
vivo
two
differ
mechan
eg
enhanc
resist
constitu
rna
strand
degrad
singlestrand
rnase
stabil
sirna
duplex
structur
critic
activ
investig
mechan
influenc
overal
biostabl
assess
integr
fetal
bovin
serum
well
human
mous
serum
either
unmodifi
sirna
silna
modifi
enhanc
exonucleas
resist
modifi
also
increas
duplex
stabil
briefli
lna
modif
end
exhibit
duplex
stabil
similar
unmodifi
c
c
wherea
six
addit
duplex
stabil
sens
strand
modif
basepair
posit
increas
c
shown
figur
b
unmodifi
sirna
markedli
degrad
h
produc
smear
faster
migrat
speci
similar
diffus
band
observ
end
protect
contrast
unmodifi
sirna
show
weak
sign
degrad
h
modifi
strike
stabil
show
sign
degrad
even
h
incub
either
undilut
human
mous
serum
figur
unmodifi
fulli
degrad
within
h
increas
degrad
rate
also
observ
littl
fulllength
product
remain
h
contrast
remain
intact
full
h
assay
human
mous
serum
verifi
experiment
compat
lna
sirna
machineri
rang
differ
lnamodifi
sirna
tabl
analys
abil
select
inhibit
firefli
luciferas
cultur
cell
express
firefli
renilla
luciferas
shown
figur
firefli
sirna
effect
select
reduc
firefli
luciferas
activ
wherea
unrel
sirna
control
essenti
without
effect
introduct
lna
modif
overhang
either
strand
firefli
sirna
reveal
loss
inhibitori
effect
one
lna
end
sens
strand
fulli
compat
activ
lna
end
antisens
strand
dramat
impair
inhibitori
effect
exclud
possibl
impair
due
lack
phosphat
shown
crucial
sirna
function
end
antisens
strand
phosphoryl
vitro
howev
procedur
recov
lost
effect
data
shown
silna
wherein
sens
strand
modifi
overhang
mani
seven
basepair
posit
retain
signific
inhibitori
activ
wherea
silna
compris
variou
combin
either
fulli
modifi
sens
antisens
strand
inhibitori
effect
data
shown
two
firefli
silna
lightli
modifi
medium
modifi
compar
unmodifi
doserespons
experi
figur
efficaci
slight
differ
potenc
estim
ec
nm
nm
wherea
somewhat
lower
efficaci
highest
dose
test
similar
potenc
estim
ec
nm
find
lna
antisens
posit
substanti
impair
function
sirna
contrast
find
braasch
et
al
recent
publish
effect
sever
chemic
modif
includ
lna
sirna
human
caveolin
determin
whether
discrep
due
differ
choic
target
repeat
analysi
time
target
renilla
luciferas
shown
figur
observ
tendenc
firefli
target
carri
modif
overhang
function
unmodifi
renilla
sirna
end
sens
strand
could
modifi
without
loss
activ
lna
antisens
end
significantli
reduc
effect
interestingli
case
part
activ
lost
result
antisens
lna
could
recov
simultan
modifi
sens
end
even
modif
also
includ
sens
end
substanti
gener
find
final
apprais
silna
target
endogen
gene
neuropeptid
npi
cell
shown
figur
unmodifi
npi
sirna
reduc
mrna
level
consider
wherea
unrel
control
sirna
dopamin
receptor
sens
strand
lna
modif
well
toler
lightli
modifi
medium
modifi
display
similar
inhibitori
effect
unmodifi
sirna
lna
antisens
modif
substanti
impair
activ
howev
could
mostli
recov
simultan
modif
sens
end
next
examin
effect
make
singl
rna
lna
exchang
basepair
posit
antisens
strand
firefli
luciferas
shown
figur
exchang
toler
test
posit
apart
antisens
end
notabl
except
posit
introduct
lna
lead
clear
decreas
inhibitori
activ
although
exclud
modif
somehow
prevent
load
antisens
strand
risc
believ
unlik
given
function
mani
significantli
modifi
silna
rather
posit
close
site
rna
target
cleavag
occur
po
sirna
strand
count
end
suspect
lna
modif
may
exert
direct
conform
function
effect
catalyt
site
lna
substitut
posit
exchang
rnau
lnat
rnac
lnam
c
lead
introduct
addit
methylgroup
nucleobas
aform
helix
form
sirnarnatarget
methyl
group
protrud
major
groov
potenti
effect
helic
geometri
access
import
catalysi
investig
detail
repeat
experi
lnau
place
lnat
posit
new
compound
display
activ
similar
unmodifi
sirna
thu
lend
support
import
nativ
nucleobas
close
cleavag
site
data
shown
replac
posit
substitut
rnaa
lnaa
indic
factor
helic
structur
access
also
import
proper
catalyt
activ
given
increas
affin
impos
lna
seem
like
one
factor
may
chang
thermodynam
fingerprint
sirna
vicin
cleavag
site
import
indic
recent
report
much
experiment
data
support
notion
cell
incorpor
strand
sirna
risc
complex
prefer
given
one
two
strand
nm
luciferas
activ
assess
h
later
firefli
luciferas
activ
normal
renilla
luciferas
activ
uninhibit
activ
plasmid
alon
set
b
doserespons
curv
select
silna
target
firefli
luciferas
total
silnasirna
concentr
kept
constant
nm
ratio
effect
irrelev
silna
sirna
vari
graph
show
log
concentr
effect
silna
one
two
repres
experi
mean
sd
deriv
duplic
sampl
c
renilla
luciferas
activ
assess
firefli
luciferas
renilla
activ
normal
firefli
luciferas
activ
npi
mrna
level
rat
cell
endogen
express
npi
transfect
silna
nm
npi
mrna
measur
h
later
quantit
pcr
npi
mrna
level
normal
cyclophilin
uninhibit
normal
npi
mrna
level
set
mean
sd
valu
case
luciferas
two
independ
experi
perform
triplic
two
independ
experi
perform
duplic
case
npi
explan
strandbia
provid
schwarz
et
al
khvorova
et
al
propos
strand
display
weakest
bind
energi
close
basepair
incorpor
preferenti
function
genom
tool
prospect
therapeut
incorpor
unwant
nontarget
complementari
sens
strand
concern
like
caus
offtarget
effect
may
lower
potenc
sirna
limit
incorpor
intend
antisens
strand
rel
bind
energi
end
sirna
duplex
determin
strand
bia
ought
possibl
favour
incorpor
antisens
strand
select
enhanc
affin
sens
end
lna
intrigu
possibl
alreadi
hint
previou
observ
activ
loss
due
lna
incorpor
antisens
end
could
larg
rescu
compensatori
modif
end
sens
strand
priori
would
serv
restor
rel
bind
energi
two
end
silna
examin
detail
abil
lna
direct
strand
load
construct
plasmid
system
made
possibl
monitor
activ
sens
antisens
strand
briefli
target
region
deriv
sar
viru
medium
effect
sirna
sar
previous
identifi
clone
utr
firefli
luciferas
gene
sens
antisens
orient
figur
sar
sirna
tabl
ident
close
basepair
end
u
make
like
enough
antisens
sens
strand
would
incorpor
risc
observ
activ
respect
target
shown
figur
modifi
overhang
sens
end
inhibit
sens
target
extent
indic
sirna
silna
effect
load
antisens
strand
risc
howev
test
sens
strand
activ
outcom
differ
sirna
show
clear
downregul
target
albeit
effect
less
observ
antisens
strand
contrast
activ
observ
silna
sens
strand
strongli
support
conclus
sens
lna
modif
alter
strandbia
favour
incorpor
antisens
strand
sirna
silna
also
test
control
plasmid
found
effect
luciferas
express
improv
low
efficaci
sirna
describ
incorpor
sens
strand
may
decreas
potenc
sirna
simpli
lower
number
risc
complex
load
antisens
strand
establish
sens
lna
appear
abl
redirect
strand
load
next
examin
whether
modif
would
also
abl
improv
potenc
two
ineffici
sirna
target
renilla
luciferas
sirna
strong
g
c
basepair
antisens
end
weak
u
basepair
sens
end
tabl
make
like
least
part
poor
activ
could
due
strand
incorpor
sens
strand
shown
figur
activ
sirna
improv
sens
lna
modif
reduc
residu
luciferas
activ
silna
silna
investig
lna
sens
modif
could
rescu
mediocr
sirna
therapeut
import
target
compar
abil
three
sirna
correspond
silna
protect
vero
cell
death
induc
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
three
sirna
reason
effect
sirna
ineffect
sirna
strong
g
c
basepair
sens
end
weak
u
basepair
antisens
tabl
stabil
lna
sens
end
expect
lead
improv
activ
consist
notion
none
observ
figur
contrast
modestli
effect
sirna
u
basepair
end
show
expect
improv
modifi
lna
decreas
increas
viral
titr
chang
rel
behaviour
sirna
silna
although
gener
greater
reduct
increas
cytotox
note
lower
higher
titer
respect
data
shown
unrel
sirna
silna
control
firefli
luciferas
npi
show
inhibit
virusinduc
cytotox
shown
nucleotid
analogu
lna
substanti
compat
sirna
intracellular
machineri
preserv
molecul
integr
whilst
offer
sever
improv
relev
develop
sirna
technolog
therapeut
use
notabl
lna
offer
mean
improv
dramat
halflif
sirna
combin
enhanc
nucleas
stabil
stabil
duplex
structur
properti
obtain
modest
number
lna
modif
affect
abil
sirna
mediat
target
knockdown
expect
silna
may
exhibit
significantli
enhanc
efficaci
administ
vivo
compar
unmodifi
counterpart
offtarget
effect
brought
inappropri
load
sirna
sens
strand
constitut
major
concern
use
sirna
genom
tool
prospect
drug
data
provid
evid
lna
use
minim
effect
act
two
differ
mechan
first
lna
substitut
alter
strandbia
select
increas
affin
close
basepair
end
sirna
sens
strand
note
analys
far
confin
ultim
sens
posit
exclud
possibl
even
greater
strandbia
may
impos
addit
modif
neighbour
posit
second
lna
may
incorpor
posit
sens
strand
load
risc
complex
impair
abil
particip
target
cleavag
identifi
activityimpair
posit
po
systemat
analys
whole
set
singl
lna
insert
antisens
strand
found
vicin
target
cleavag
site
evid
similar
substitut
appli
sens
strand
similar
effect
indirect
nevertheless
see
reason
believ
case
combin
two
activityimpair
lna
modif
may
facilit
complet
loss
activ
risc
complex
inappropri
load
sens
strand
abil
influenc
strand
load
lna
modif
sens
end
also
provid
opportun
improv
potenc
ineffect
sirna
enhanc
antisens
strand
incorpor
risc
although
data
demonstr
enhanc
load
gener
phenomenon
option
use
lna
way
choic
target
sequenc
restrain
consist
find
braasch
et
al
present
data
confirm
excess
lna
modif
permiss
introduc
separ
modif
reduc
knockdown
efficaci
sirna
base
present
data
specul
underli
caus
may
includ
chang
sirna
structur
affect
risc
load
problem
unwind
duplex
due
excess
thermost
chang
releas
kinet
substrat
cleavag
etc
whatev
caus
shown
potenti
key
therapeut
benefit
introduc
lna
sirna
achiev
rel
modif
compromis
sirna
activ
modif
lna
shown
provid
benefit
sirna
could
conceiv
success
combin
lna
conclus
rnalik
charact
lna
combin
enhanc
biophys
characterist
eg
increas
nucleas
resist
affin
enabl
us
construct
hybrid
rnalna
molecul
new
favour
properti
unmodifi
sirna
anticip
new
molecul
term
silna
impact
posit
use
rnai
technolog
function
genom
broader
perspect
translat
technolog
drug
platform
figur
lna
improv
mediumeffici
sirna
renilla
luciferas
activ
effect
sirna
silna
depend
target
sequenc
differ
target
sequenc
accordingli
also
b
effect
sirna
silna
sarsinduc
cytotox
depend
target
sequenc
sar
vero
cell
transfect
nm
sirna
silna
infect
sarscov
sarsinduc
cytotox
assess
h
later
untransfect
infect
sampl
set
cytotox
mean
sd
valu
renilla
case
two
experi
perform
triplic
sar
case
three
experi
perform
quadrupl
